14 January 2025 IP specialist joins firm’s Bristol office | Transaction expert has advised AstraZeneca, Cancer Research Horizons, and other high-profile clients.
14 January 2025
9 January 2025
9 January 2025
7 January 2025
Latest Features
Americas
Key developments for the industry this year include a more pro-patent administration and USPTO changes, say Carla Ji-Eun Kim and Deborah Sterling of Sterne Kessler.
Americas
The act’s one-sided provisions and its disproportionate remedies cannot pass constitutional muster, argues John Cox of Barnes & Thornburg.
Americas
Key similarities and differences between the patent systems, particularly in biotech, offer lessons and opportunities for rightsholders, say Daniela Fasoli of Simões Propriedade Intelectual and Jeffrey Morton of Haynes and Boone.
Asia
Free trade zones in Beijing, Shanghai, Guangdong, and Hainan are designed to attract capital into China’s fast-growing healthcare sectors, says Li Mi of Lusheng.
Americas
Well-drafted contracts and ironclad tech security can save time and money when an ex-employee steals IP ‘like sugar packets in Starbucks’, finds Tom Phillips.
Asia
The Beijing IP court’s decision to revive a key semaglutide patent based on experimental data has far-reaching legal and economic implications, says Jennifer Che of Eagle IP
Asia
Recent updates to China’s patent law provide guidelines on PTA calculations, definitions of delays and challenging decisions, say Audrey Cheung, Yolanda Wang and Jennifer Che of Eagle IP.
Biotechnology
The shift towards preventative pharmaceuticals could open new, and highly valuable, markets but it must be strengthened by patent rights, says Sam Andrews, senior paralegal at Powell Gilbert.
More News
7 January 2025 Two large teams leave Locke Lord following Troutman Pepper merger | Buchanan opens Chicago office with a large life sciences group | Shoosmiths adds team in London to expand brand-focused IP services.
7 January 2025 New partner brings technical background in computer science and more than a decade experience in patent litigation | Expertise in tech, engineering, chemical, and life sciences sectors.
2 January 2025 The Japanese pharma company files complaint against Lupin Pharmaceuticals | Suit alleges patent infringement over the company’s proposed generic version of a key ALS drug.
24 December 2024 Dispute stems from Amneal’s efforts to market generic version of Teva’s inhaler for treating asthma | Precedential decision could restrict how brand-name pharmaceutical companies use the Orange Book to extend market exclusivity.
24 December 2024 Massachusetts medical research company is awarded damages following a jury verdict that found a Japanese pharma had infringed on its patent | Patent relates to Duchenne muscular dystrophy treatment.
19 December 2024 Pair of generic drug makers challenged validity of patent on priority, novelty and inventive step | EPO found the patent did not introduce any new matter not originally disclosed in the pharma company’s application.
17 December 2024 LSIPR’s key event series to host its inaugural ceremony next year in Boston | Spotlight on top innovators and firms in life sciences IP | Gala to honour contributions across 21 categories with 15 judges.
Get up-to-date information on all our publications and events
Get critical life sciences news direct to your inbox